Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Lema Gerald, Director. Director active across 1 company, notably FIBROGEN INC. Cumulatively, 3 reports have been logged. History available since 26 May 2021. The latest transaction was filed on 7 June 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Gerald Lema serves as a Director at FibroGen Inc. As a board member, he contributes to overseeing the company's operations and shaping its strategy. Gerald brings expertise in the biopharmaceutical sector, helping FibroGen innovate and grow. His commitment to corporate governance is essential for ensuring transparency and accountability within the organization.